Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
First Claim
1. A method comprising administering a therapeutically effective amount of an agent to a mammal which has an allergic or inflammatory disease, wherein said agent inhibits an activity or expression of a component of an arginine metabolic pathway in a tissue affected by the disease, and said component is not a nitric oxide synthase (NOS).
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides compositions and methods useful for detecting or treating asthma or other allergic or inflammatory diseases. In one aspect, the methods of the present invention include inhibiting the activity or expression of a component of an arginine metabolic pathway in tissues affected by asthma or other allergic or inflammatory diseases. In many embodiments, the component being inhibited is a cationic amino acid transporter, an arginase, or a component downstream of the arginase. In many other embodiments, the activity or expression of the component is inhibited by an agent that binds to the component. In still many other embodiments, the activity or expression of the component is inhibited by an agent that binds a polynucleotide encoding the component.
-
Citations
20 Claims
- 1. A method comprising administering a therapeutically effective amount of an agent to a mammal which has an allergic or inflammatory disease, wherein said agent inhibits an activity or expression of a component of an arginine metabolic pathway in a tissue affected by the disease, and said component is not a nitric oxide synthase (NOS).
-
15. A method for identifying an agent for treating an allergic or inflammatory disease, comprising:
-
contacting a molecule with a tissue affected by asthma or another allergic or inflammatory disease, wherein said molecule is capable of binding to a non-NOS component of an arginine metabolic pathway or to a polynucleotide encoding said component; and
determining if said molecule is capable of ameliorating or eliminating a syndrome or phenotype associated with said asthma or disease. - View Dependent Claims (16, 17)
-
-
18. A method, comprising:
-
detecting an expression profile of at least one gene in a biological sample of a mammal; and
comparing said expression profile to a reference expression profile of said at least one gene to determine if the mammal has or is at risk for an allergic or inflammatory disease, wherein said one gene encodes a non-NOS component of an arginine metabolic pathway. - View Dependent Claims (19)
-
-
20. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier and an agent capable of inhibiting an activity or expression of a non-NOS component of an arginine metabolic pathway.
Specification